/Directory/Medical Research/

Birth Defects & Genetic Diseases Research

Nonprofit OrganizationsBirth Defects & Genetic Diseases Research

Birth Defects & Genetic Diseases Research organizations account for 182 organizations in the United States. In aggregate, these organizations generate $945m in revenue and employ 4.2k individuals.

182

Active Organizations

$945.2 Million

Annual Revenue

4 Thousand

Employees in Sector

$2.2 Billion

Controlled Assets

Explore Nonprofits in the Birth Defects & Genetic Diseases Research Sector

Broad Institute Inc

Cambridge, MA

Assets: $2b

Revenue: $587m

MISSION:

The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.

New York Stem Cell Foundation Inc

New York, NY

Assets: $76m

Revenue: $44m

MISSION:

SEE SCHEDULE O.TO ADVANCE THE MOST CUTTING-EDGE STEM CELL RESEARCH IN THE WORLD, TO SUPPORT STEM CELL SCIENTISTS, AND TO EDUCATE THE PUBLIC.

Altius Institute For Biomedical Sciences

Seattle, WA

Assets: $61m

Revenue: $44m

MISSION:

TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.

Cardiovascular Research Foundation

New York, NY

Assets: $57m

Revenue: $52m

MISSION:

CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE.

The National Hemophilia Foundation

New York, NY

Assets: $47m

Revenue: $26m

MISSION:

THE NATIONAL HEMOPHILIA FOUNDATION (NHF) IS DEDICATED TO FINDING CURES FOR INHERITABLE BLOOD DISORDERS AND TO ADDRESSING AND PREVENTING THE COMPLICATIONS OF THESE DISORDERS THROUGH RESEARCH, EDUCATION, AND ADVOCACY ENABLING PEOPLE AND FAMILIES TO THRIVE.

The Foundation For Embryonic Competence Inc

Basking Ridge, NJ

Assets: $27m

Revenue: $15m

MISSION:

THE FOUNDATION FOR EMBRYONIC COMPETENCE, INC., FORMERLY KNOWN AS " THE FOUNDATION FOR THE ASSESSMENT AND ENHANCEMENT OF EMBRYONIC COMPETENCE, INC." (FOUNDATION) IS A NEW JERSEY NON-PROFIT CORPORATION, INCORPORATED IN 2013. THE FOUNDATION'S ACTIVITIES ARE CONDUCTED AT ITS SOLE LOCATION, 140 ALLEN ROAD IN BASKING RIDGE, NEW JERSEY. THE MISSION OF THE FOUNDATION IS ADVANCING KNOWLEDGE AND ENHANCING OUTCOMES IN EMBRYONIC RESEARCH, DIAGNOSIS, AND EDUCATION.

Hauptman-Woodward Medical Research Institute Inc

Buffalo, NY

Assets: $26m

Revenue: $9m

MISSION:

GUIDED BY ITS MOTTO, CURE-OSITY, THE HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE (HWI) CREATES NOVEL STRATEGIES AND TECHNOLOGIES TO PROMOTE THE UNDERSTANDING, PREVENTION, AND TREATMENT OF MANY HUMAN DISEASES. HWI SCIENTISTS CONDUCT BASIC, FUNDAMENTAL RESEARCH THAT WILL PROVIDE THE FOUNDATION FOR EFFECTIVE THERAPEUTIC APPROACHES FAR INTO THE FUTURE. OFTEN OUR RESEARCH INCLUDES IDENTIFYING PROTEINS INVOLVED IN DISEASE WHICH ALLOWS TREATMENTS TO BE MORE EFFECTIVE BY TARGETING THOSE PROTEINS. EXAMPLES OF CURRENT PROJECTS INCLUDE BREAST CANCER, PROSTATE CANCER, MULTIPLE MYELOMA, STUDYING THE EFFECT OF GRAVITY ON CELLS, AND BIOLOGICAL CELL STRUCTURE DETERMINATION FOR NEARLY ALL DISEASE THROUGH THE USE OF HARD X-RAY FREE ELECTRON LASERS (XFELS) AND HIGH-THROUGHPUT CRYSTALLIZATION.

American Society Of Human Genetics

Rockville, MD

Assets: $24m

Revenue: $8m

MISSION:

The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.

Greenwood Genetic Center Inc

Greenwood, SC

Assets: $23m

Revenue: $25m

MISSION:

THE GREENWOOD GENETIC CENTER IS A NONPROFIT INSTITUTE CENTERED ON CLINICAL GENETIC SERVICES, DIAGNOSTIC LABORATORY TESTING, EDUCATIONAL PROGRAMS AND RESOURCES, AND RESEARCH. WITH A FOCUS ON COMPASSIONATE PATIENT CARE AND INNOVATIVE SCIENTIFIC ADVANCEMENT, WE KEEP EVERY PATIENT AND THEIR FAMILIES AT THE FOREFRONT OF EVERYTHING WE DO. WE HAVE A VARIETY OF CLINIC LOCATIONS TO SERVE PATIENTS AND FAMILIES ACROSS THE LIFESPAN WITH A VARIETY OF GENETIC NEEDS AND CONCERNS.

Philadelphia Fight

Philadelphia, PA

Assets: $17m

Revenue: $52m

MISSION:

The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.

Hereditary Disease Foundation

New York, NY

Assets: $16m

Revenue: $4m

MISSION:

TO FUND INNOVATIVE RESEARCH TOWARDS CURING HUNTINGTON'S DISEASE AND IMPACTING OTHER BRAIN DISORDERS.

Hearing Health Foundation

New York, NY

Assets: $12m

Revenue: $6m

MISSION:

PREVENT AND CURE HEARING LOSS AND TINNITUS THROUGH GROUNDBREAKING RESEARCH. (SEE SCH O ) HEARING HEALTH FOUNDATION'S VISION IS TO HAVE A WORLD WHERE PEOPLE CAN ENJOY LIFE WITHOUT HEARING LOSS AND TINNITUS. SINCE 1958, HEARING HEALTH FOUNDATION HAS BEEN THE LEADING NONPROFIT FUNDER FOR FUNDING FOR BASIC, CLINICAL AND TRANSLATIONAL RESEARCH IN HEARING AND BALANCE SCIENCE, AND A LEADER IN DRIVING NEW INNOVATIONS AND TREATMENTS FOR PEOPLE WITH HEARING LOSS, TINNITUS, AND OTHER HEARING CONDITIONS. THIS INCLUDES FUNDING RESEARCH THAT LED TO THE DEVELOPMENT OF COCHLEAR IMPLANTS AND MANY OF TODAY'S STANDARD TREATMENTS FOR OTOSCLEROSIS (ABNORMAL BONE GROWTH IN THE EAR) AND EAR INFECTIONS. IN THE 1990'S HEARING HEALTH FOUNDATION ADVOCATED IN WASHINGTON, DC, FOR THE UNIVERSAL NEWBORN HEARING SCREENING LEGISLATION, TO DETECT HEARING LOSS AT BIRTH. TODAY, 97% OF NEWBORNS ARE TESTED (UP FROM 4% IN 1994).

The American Society Of Gene & Cell Therapy

Waukesha, WI

Assets: $12m

Revenue: $7m

MISSION:

ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE.

American Society For Transplantation & Cellular Therapy

Chicago, IL

Assets: $11m

Revenue: $6m

MISSION:

IMPROVE BLOOD AND MARROW TRANSPLANTATION AND RELATED CELLULAR THERAPIES

Center For Human Genetics Inc

Cambridge, MA

Assets: $10m

Revenue: $2m

MISSION:

TO FUNCTION AS A LOCAL AND NATIONAL CLINIC AND DIAGNOSTIC REFERENCE RESOURCE FOR BIRTH DEFECTS AND GENETIC DISORDERS.

Puerto Rico Community For Clinical Services Research And Health

San Juan, PR

Assets: $9m

Revenue: $11m

MISSION:

EARLY INTERVENTION AND PRIMARY CLINIC DENTAL CARE CLINIC MENTAL HEALTH HIV ANTIBODY TESTING MEDICINE PROVISION MEDICAL CARE MANAGEM

Fshd Society

Randolph, MA

Assets: $6m

Revenue: $4m

MISSION:

INCREASE AWARENESS, UNDERSTANDING OF AND CONDUCT RESEARCH ON FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY.

National Ovarian Cancer Coalition Inc

Dallas, TX

Assets: $5m

Revenue: $4m

MISSION:

TO SAVE LIVES THROUGH THE PREVENTION AND CURE OF OVARIAN CANCER AND TO IMPROVE THE QUALITY OF LIFE FOR SURVIVORS AND THEIR CAREGIVERS.

Spinal Research Foundation

Reston, VA

Assets: $5m

Revenue: $2m

MISSION:

The goal of this organization is to conduct research which can be used to improve the prevention, diagnosis and treatment of any of a number of illnesses or conditions that are hereditary and passed from parent to offspring.

International Society For Cellular Therapy

Assets: $5m

Revenue: $2m

MISSION:

TO DRIVE THE TRANSLATION OF ALL CELLULAR THERAPIES FOR THE BENEFIT OF PATIENTS WORLDWIDE.